Ranitidine reverses gallamine paralysis in rats.
The effect of ranitidine on gallamine-induced depression of twitch tension was evaluated in urethane-anaesthetized and mechanically ventilated male Sprague-Dawley rats. Gallamine was administered as an intravenous (IV) bolus and constant rate infusion in 15 rats to maintain 89 +/- 7% (SE) depression of twitch tension induced by electrical stimulation of a sciatic nerve. Ranitidine, IV at either 0.5, 1, 2.5, 5, or 10 mg/kg, was then administered into groups of three rats. Ranitidine produced an immediate dose- and serum concentration-dependent reversal (antagonism) of the twitch tension depression induced with gallamine. The reversal was observed within approximately 30 s and was maintained for 3-26 (12 +/- 2) min. The dose of ranitidine that produced 50% reversal was 2.9 +/- 0.1 mg/kg, and this reversal was associated with a ranitidine serum concentration of 5.2 +/- 0.3 micrograms/mL. Ranitidine administered alone (and without gallamine) did not alter twitch tension at either 2.5 or 20 mg/kg. In addition, ranitidine did not alter either the gallamine neuromuscular blocking concentration in serum or the serum clearance of gallamine. Ranitidine reverses the neuromuscular action of gallamine, and this effect of ranitidine is not due to a pharmacokinetic interaction between ranitidine and gallamine.
Mishra
Y
Y
Pharmacy Department, University of Sydney, New South Wales, Australia.
Ramzan
I
I
D000818:Animals; D005703:Gallamine Triethiodide / Q000037:antagonists & inhibitors* / Q000633:toxicity; D008297:Male; D010243:Paralysis / Q000139:chemically induced* / Q000188:drug therapy; D011899:Ranitidine / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley
D011899:Ranitidine; D005703:Gallamine Triethiodide